Better Buy: Eli Lilly and Co. vs. Merck & Co., Inc.

Better Buy: Eli Lilly and Co. vs. Merck & Co., Inc.

These big pharma stocks have something for everyone. Income investors love the dividends Eli Lilly and Co. (NYSE: LLY) and Merck & Co., Inc. (NYSE: MRK) pay each quarter, while dreams of successful new drug launches attract growth-minded investors. 

Lilly's stock price has risen in line with the broader market this year, but Merck tanked in October. Let's take a closer look at the threats and opportunities facing both to see which of these big pharma stocks is the better pick right now. 

Image source: Getty Images.

Continue reading

Source: Fool.com